Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress
Upregulation of xCT, the inducible subunit of a membrane-bound amino acid transporter, replenishes intracellular glutathione stores to maintain cell viability in an environment of oxidative stress. xCT also serves as a fusion-entry receptor for the Kaposi's sarcoma-associated herpesvirus (KSHV), the causative agent of Kaposi's sarcoma (KS). Ongoing KSHV replication and infection of new cell targets is important for KS progression, but whether xCT regulation within the tumor microenvironment plays a role in KS pathogenesis has not been determined. Using gene transfer and whole virus infection experiments, we found that KSHV-encoded microRNAs (KSHV miRNAs) upregulate xCT expression by macrophages and endothelial cells, largely through miR-K12-11 suppression of BACH-1—a negative regulator of transcription recognizing antioxidant response elements within gene promoters. Correlative functional studies reveal that upregulation of xCT by KSHV miRNAs increases cell permissiveness for KSHV infection and protects infected cells from death induced by reactive nitrogen species (RNS). Interestingly, KSHV miRNAs simultaneously upregulate macrophage secretion of RNS, and biochemical inhibition of RNS secretion by macrophages significantly reduces their permissiveness for KSHV infection. The clinical relevance of these findings is supported by our demonstration of increased xCT expression within more advanced human KS tumors containing a larger number of KSHV-infected cells. Collectively, these data support a role for KSHV itself in promoting de novo KSHV infection and the survival of KSHV-infected, RNS-secreting cells in the tumor microenvironment through the induction of xCT.
Vyšlo v časopise:
Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000742
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000742
Souhrn
Upregulation of xCT, the inducible subunit of a membrane-bound amino acid transporter, replenishes intracellular glutathione stores to maintain cell viability in an environment of oxidative stress. xCT also serves as a fusion-entry receptor for the Kaposi's sarcoma-associated herpesvirus (KSHV), the causative agent of Kaposi's sarcoma (KS). Ongoing KSHV replication and infection of new cell targets is important for KS progression, but whether xCT regulation within the tumor microenvironment plays a role in KS pathogenesis has not been determined. Using gene transfer and whole virus infection experiments, we found that KSHV-encoded microRNAs (KSHV miRNAs) upregulate xCT expression by macrophages and endothelial cells, largely through miR-K12-11 suppression of BACH-1—a negative regulator of transcription recognizing antioxidant response elements within gene promoters. Correlative functional studies reveal that upregulation of xCT by KSHV miRNAs increases cell permissiveness for KSHV infection and protects infected cells from death induced by reactive nitrogen species (RNS). Interestingly, KSHV miRNAs simultaneously upregulate macrophage secretion of RNS, and biochemical inhibition of RNS secretion by macrophages significantly reduces their permissiveness for KSHV infection. The clinical relevance of these findings is supported by our demonstration of increased xCT expression within more advanced human KS tumors containing a larger number of KSHV-infected cells. Collectively, these data support a role for KSHV itself in promoting de novo KSHV infection and the survival of KSHV-infected, RNS-secreting cells in the tumor microenvironment through the induction of xCT.
Zdroje
1. LuppiM
BarozziP
SchulzTF
SettiG
StaskusK
2000 Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 343 1378 1385
2. SoulierJ
GrolletL
OksenhendlerE
CacoubP
Cazals-HatemD
1995 Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 1276 1280
3. CesarmanE
ChangY
MoorePS
SaidJW
KnowlesDM
1995 Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332 1186 1191
4. ChangY
CesarmanE
PessinMS
LeeF
CulpepperJ
1994 Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 1865 1869
5. EngelsEA
BiggarRJ
HallHI
CrossH
CrutchfieldA
2008 Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123 187 194
6. BonnetF
LewdenC
MayT
HeripretL
JouglaE
2004 Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 101 317 324
7. LebbeC
LegendreC
FrancesC
2008 Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 22 252 261
8. ShepherdFA
MaherE
CardellaC
ColeE
GreigP
1997 Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol 15 2371 2377
9. Cook-MozaffariP
NewtonR
BeralV
BurkittDP
1998 The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78 1521 1528
10. VanniT
SprinzE
MachadoMW
Santana RdeC
FonsecaBA
2006 Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev 32 445 455
11. MaurerT
PonteM
LeslieK
2007 HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 357 1352 1353
12. KrownSE
LeeJY
DittmerDP
2008 More on HIV-associated Kaposi's sarcoma. N Engl J Med 358 535 536; author reply 536
13. Von RoennJH
2003 Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am 17 747 762
14. SchulzTF
2006 The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208 187 198
15. CampbellTB
BorokM
GwanzuraL
MaWhinneyS
WhiteIE
2000 Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS 14 2109 2116
16. QuinlivanEB
ZhangC
StewartPW
KomoltriC
DavisMG
2002 Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis 185 1736 1744
17. DupinN
FisherC
KellamP
AriadS
TulliezM
1999 Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A 96 4546 4551
18. KedesDH
GanemD
1997 Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99 2082 2086
19. MartinDF
KuppermannBD
WolitzRA
PalestineAG
LiH
1999 Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340 1063 1070
20. LambertM
GannageM
KarrasA
AbelM
LegendreC
2006 Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood 108 3871 3880
21. BihlF
MosamA
HenryLN
ChisholmJV3rd
DollardS
2007 Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. AIDS 21 1245 1252
22. GrundhoffA
GanemD
2004 Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113 124 136
23. LebbeC
de CremouxP
MillotG
PodgorniakMP
VerolaO
1997 Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon. Arch Dermatol Res 289 421 428
24. TsuchiyaS
KobayashiY
GotoY
OkumuraH
NakaeS
1982 Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42 1530 1536
25. LoM
WangYZ
GoutPW
2008 The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol 215 593 602
26. KaleebaJA
BergerEA
2006 Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science 311 1921 1924
27. VeettilMV
SadagopanS
Sharma-WaliaN
WangFZ
RaghuH
2008 Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the post entry stage of infection. J Virol 82 12126 12144
28. SirianniMC
VincenziL
FiorelliV
TopinoS
ScalaE
UcciniS
AngeloniA
FaggioniA
CerimeleD
CottoniF
AiutiF
EnsoliB
Gamma-interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood monocytes and lesional macrophages. Blood 1998; 91(3) 968 76
29. RappoccioloG
JenkinsFJ
HenslerHR
PiazzaP
JaisM
2006 DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 176 1741 1749
30. GanemD
ZiegelbauerJ
2008 MicroRNAs of Kaposi's sarcoma-associated herpes virus. Semin Cancer Biol 18 437 440
31. CaiX
LuS
ZhangZ
GonzalezCM
DamaniaB
2005 Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 102 5570 5575
32. SamolsMA
HuJ
SkalskyRL
RenneR
2005 Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 79 9301 9305
33. PfefferS
SewerA
Lagos-QuintanaM
SheridanR
SanderC
2005 Identification of microRNAs of the herpesvirus family. Nat Methods 2 269 276
34. SasakiH
SatoH
Kuriyama-MatsumuraK
SatoK
MaebaraK
2002 Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 277 44765 44771
35. IshiiT
ItohK
TakahashiS
SatoH
YanagawaT
2000 Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275 16023 16029
36. SkalskyRL
SamolsMA
PlaisanceKB
BossIW
RivaA
2007 Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 81 12836 12845
37. DhakshinamoorthyS
JainAK
BloomDA
JaiswalAK
2005 Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 280 16891 16900
38. DhakshinamoorthyS
JaiswalAK
2002 c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 21 5301 5312
39. HongYK
ForemanK
ShinJW
HirakawaS
CurryCL
2004 Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36 683 685
40. RodriguezA
VigoritoE
ClareS
WarrenMV
CouttetP
2007 Requirement of bic/microRNA-155 for normal immune function. Science 316 608 611
41. ParsonsCH
AdangLA
OverdevestJ
O'ConnorCM
TaylorJR,Jr.
2006 KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J Clin Invest 116 1963 1973
42. GoutPW
KangYJ
BuckleyDJ
BruchovskyN
BuckleyAR
1997 Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia 11 1329 1337
43. GoutPW
SimmsCR
RobertsonMC
2003 In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs 14 21 29
44. SamolsMA
SkalskyRL
MaldonadoAM
RivaA
LopezMC
2007 Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3 e65 doi:10.1371/journal.ppat.0030065
45. GuidarelliA
ScioratiC
ClementiE
CantoniO
2006 Peroxynitrite mobilizes calcium ions from ryanodine-sensitive stores, a process associated with the mitochondrial accumulation of the cation and the enforced formation of species mediating cleavage of genomic DNA. Free Radic Biol Med 41 154 164
46. FreyRS
Ushio-FukaiM
MalikA
2009 NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and Pathophysiology. Antioxid Redox Signal 11 791 810
47. LambethJD
2004 NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4 181 189
48. AsehnouneK
StrassheimD
MitraS
KimJY
AbrahamE
2004 Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172 2522 2529
49. LeeSJ
KimKM
NamkoongS
KimCK
KangYC
2005 Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem 280 5781 5788
50. MallerySR
PeiP
LandwehrDJ
ClarkCM
BradburnJE
2004 Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis 25 597 603
51. AlexanderJH
ReynoldsHR
StebbinsAL
DzavikV
HarringtonRA
2007 Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA 297 1657 1666
52. PakF
PyakuralP
KokhaeiP
KaayaE
PourfathollahAA
2005 HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. J Cutan Pathol 32 21 27
53. PyakurelP
MassambuC
Castanos-VelezE
EricssonS
KaayaE
2004 Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma. J Acquir Immune Defic Syndr 36 678 683
54. GillPS
TsaiYC
RaoAP
SpruckCH3rd
ZhengT
1998 Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A 95 8257 8261
55. StaskusKA
ZhongW
GebhardK
HerndierB
WangH
1997 Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71 715 719
56. BoulangerE
DuprezR
DelabesseE
GabarreJ
MacintyreE
2005 Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells. Int J Cancer 115 511 518
57. AdangLA
TomescuC
LawWK
KedesDH
2007 Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components. J Virol 81 5079 5090
58. BabcockGJ
DeckerLL
FreemanRB
Thorley-LawsonDA
1999 Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med 190 567 576
59. AdangLA
ParsonsCH
KedesDH
2006 Asynchronous progression through the lytic cascade and variations in intracellular viral loads revealed by high-throughput single-cell analysis of Kaposi's sarcoma-associated herpesvirus infection. J Virol 80 10073 10082
60. ZhuJ
LiS
MarshallZM
WhortonAR
2008 A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin. Am J Physiol Cell Physiol 294 C1012 1020
61. McAllisterSC
HansenSG
RuhlRA
RaggoCM
DeFilippisVR
2004 Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 103 3465 3473
62. WeningerW
RendlM
PammerJ
MildnerM
TschugguelW
1998 Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest 78 949 955
63. PyoCW
LeeSH
ChoiSY
2008 Oxidative stress induces PKR-dependent apoptosis via IFN-gamma activation signaling in Jurkat T cells. Biochem Biophys Res Commun 377 1001 1006
64. YanagisawaN
ShimadaK
MiyazakiT
KumeA
KitamuraY
2008 Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis 7 48
65. KimSY
KimTB
MoonKA
KimTJ
ShinD
2008 Regulation of pro-inflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo. Exp Mol Med 40 461 476
66. MaQ
CavallinLE
YanB
ZhuS
DuranEM
2009 Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci U S A 106 8683 8688
67. ThurauM
MarquardtG
Gonin-LaurentN
WeinlanderK
NaschbergerE
2009 Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J Virol 83 598 611
68. YuJY
ChungKH
DeoM
ThompsonRC
TurnerDL
2008 MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res 314 2618 2633
69. TomescuC
LawWK
KedesDH
2003 Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J Virol 77 9669 9684
70. TsutsumiS
ScrogginsB
KogaF
LeeMJ
TrepelJ
2008 A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 27 2478 2487
71. GraysonW
PantanowitzL
2008 Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol 3 31
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen